Letter to the editor commenting on ‘decreased anti-parietal cell antibody titer in the advanced phase of autoimmune gastritis’ by Nishizawa et al.

Xiaopei Guoa Department of Gastroenterology and Hepatology, Erasmus University Medical Center, Rotterdam, The NetherlandsView further author information

Marco W. J. Schreursb Department of Immunology, Erasmus University Medical Center, Rotterdam, The NetherlandsView further author information

Michail Doukasc Department of Pathology, Erasmus University Medical Center, Rotterdam, The Netherlands

https://orcid.org/0000-0002-8611-840X View further author information

Manon C. W. Spaandera Department of Gastroenterology and Hepatology, Erasmus University Medical Center, Rotterdam, The NetherlandsView further author information

Gwenny M. Fuhlera Department of Gastroenterology and Hepatology, Erasmus University Medical Center, Rotterdam, The NetherlandsCorrespondence[email protected]

https://orcid.org/0000-0001-9221-4855 View further author information

References

Nishizawa T, Watanabe H, Yoshida S, et al. Decreased anti-parietal cell antibody titer in the advanced phase of autoimmune gastritis. Scand J Gastroenterol. 2022;57(2):143–148.
PubMed Web of Science ®Google Scholar
Song M, Camargo MC, Katki HA, et al. Association of antiparietal cell and anti-Intrinsic factor antibodies with risk of gastric cancer. JAMA Oncol. 2022;8(2):268–274.
PubMed Web of Science ®Google Scholar
Pimentel-Nunes P, Libânio D, Marcos-Pinto R, et al. Management of epithelial precancerous conditions and lesions in the stomach (MAPS II): European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter and Microbiota Study Group (EHMSG), European Society of Pathology (ESP), and Sociedade Portuguesa de Endoscopia Digestiva (SPED) Guideline Update 2019. Endoscopy. 2019;51:365–388.
PubMed Web of Science ®Google Scholar
Tozzoli R, Kodermaz G, Perosa AR, et al. Autoantibodies to parietal cells as predictors of atrophic body gastritis: a five-year prospective study in patients with autoimmune thyroid diseases. Autoimmun Rev. 2010;10(2):80–83.
PubMed Web of Science ®Google Scholar
den Hollander WJ, Holster IL, den Hoed CM, et al. Surveillance of premalignant gastric lesions: a multicentre prospective cohort study from low incidence regions. Gut. 2019;68(4):585–593.
PubMed Web of Science ®Google Scholar

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Letter to the editor commenting on ‘decreased anti-parietal cell antibody titer in the advanced phase of autoimmune gastritis’ by Nishizawa et al.

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Letter to the editor commenting on ‘decreased anti-parietal cell antibody titer in the advanced phase of autoimmune gastritis’ by Nishizawa et al.

References

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date